{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:09:00Z","timestamp":1761919740528},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2013,9,21]],"date-time":"2013-09-21T00:00:00Z","timestamp":1379721600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1007\/s10147-013-0607-9","type":"journal-article","created":{"date-parts":[[2013,9,20]],"date-time":"2013-09-20T03:34:23Z","timestamp":1379648063000},"page":"943-945","source":"Crossref","is-referenced-by-count":11,"title":["Current therapeutic strategies for childhood hepatic malignant tumors"],"prefix":"10.1007","volume":"18","author":[{"given":"Eiso","family":"Hiyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,9,21]]},"reference":[{"key":"607_CR1","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1634\/theoncologist.2008-0011","volume":"13","author":"JB Litten","year":"2008","unstructured":"Litten JB, Tomlinson GE (2008) Liver tumors in children. Oncologist 13:812\u2013820","journal-title":"Oncologist"},{"key":"607_CR2","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1002\/lt.21654","volume":"14","author":"MJ Finegold","year":"2008","unstructured":"Finegold MJ, Egler RA, Goss JA et al (2008) Liver tumors: pediatric population. Liver Transpl 14:1545\u20131556","journal-title":"Liver Transpl"},{"key":"607_CR3","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1053\/jhep.2003.50375","volume":"38","author":"A Darbari","year":"2003","unstructured":"Darbari A, Sabin KM, Shapiro CN et al (2003) Epidemiology of primary hepatic malignancies in U.S. children. Hepatology 38:560\u2013566","journal-title":"Hepatology"},{"key":"607_CR4","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.clinre.2012.03.030","volume":"36","author":"B Bail Le","year":"2012","unstructured":"Le Bail B (2012) Pathology: a pictorial review. A selected atlas of paediatric liver pathology. Clin Res Hepatol Gastroenterol 36:248\u2013252","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"607_CR5","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1200\/JCO.2000.18.14.2665","volume":"18","author":"JA Ortega","year":"2000","unstructured":"Ortega JA, Douglass EC, Feusner JH et al (2000) Randomized comparison of cisplatin\/vincristine\/fluorouracil and cisplatin\/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: a report from the Children\u2019s Cancer Group and the Pediatric Oncology Group. J Clin Oncol 18:2665\u20132675","journal-title":"J Clin Oncol"},{"key":"607_CR6","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1200\/JCO.2000.18.22.3819","volume":"18","author":"J Pritchard","year":"2000","unstructured":"Pritchard J, Brown J, Shafford E et al (2000) Cisplatin, doxorubicin, and delayed surgery for childhood hepatoblastoma: a successful approach\u2014results of the first prospective study of the International Society of Pediatric Oncology. J Clin Oncol 18:3819\u20133828","journal-title":"J Clin Oncol"},{"key":"607_CR7","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1056\/NEJMoa0810613","volume":"361","author":"G Perilongo","year":"2009","unstructured":"Perilongo G, Maibach R, Shafford E et al (2009) Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma. N Engl J Med 361:1662\u20131670","journal-title":"N Engl J Med"},{"key":"607_CR8","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1002\/pbc.22088","volume":"53","author":"RL Meyers","year":"2009","unstructured":"Meyers RL, Rowland JR, Krailo M et al (2009) Predictive power of pretreatment prognostic factors in children with hepatoblastoma: a report from the Children\u2019s Oncology Group. Pediatr Blood Cancer 53:1016\u20131022","journal-title":"Pediatr Blood Cancer"},{"key":"607_CR9","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jpedsurg.2004.01.035","volume":"39","author":"BJ Dicken","year":"2004","unstructured":"Dicken BJ, Bigam DL, Lees GM (2004) Association between surgical margins and long-term outcome in advanced hepatoblastoma. J Pediatr Surg 39:721\u2013725","journal-title":"J Pediatr Surg"},{"key":"607_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00383-010-2708-0","volume":"27","author":"T Hishiki","year":"2011","unstructured":"Hishiki T, Matsunaga T, Sasaki F et al (2011) Outcome of hepatoblastomas treated using the Japanese Study Group for Pediatric Liver Tumor (JPLT) protocol-2: report from the JPLT. Pediatr Surg Int 27:1\u20138","journal-title":"Pediatr Surg Int"},{"key":"607_CR11","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S1470-2045(13)70272-9","volume":"14","author":"J Zsiros","year":"2013","unstructured":"Zsiros J, Brugieres L, Brock P et al (2013) Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study. Lancet Oncol 14:834\u2013842","journal-title":"Lancet Oncol"},{"key":"607_CR12","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/pbc.24214","volume":"59","author":"D Lopez-Terrada","year":"2012","unstructured":"Lopez-Terrada D, Zimmermann A (2012) Current issues and controversies in the classification of pediatric hepatocellular tumors. Pediatr Blood Cancer 59:780\u2013784","journal-title":"Pediatr Blood Cancer"},{"key":"607_CR13","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1200\/JCO.2010.29.3837","volume":"29","author":"MH Malogolowkin","year":"2011","unstructured":"Malogolowkin MH, Katzenstein HM, Meyers RL et al (2011) Complete surgical resection is curative for children with hepatoblastoma with pure fetal histology: a report from the Children\u2019s Oncology Group. J Clin Oncol 29:3301\u20133306","journal-title":"J Clin Oncol"},{"key":"607_CR14","doi-asserted-by":"crossref","unstructured":"Lopez-Terrada D, Alaggio R, De D\u00e1vila MT et al (2013) Towards an International Pediatric Liver Tumor Consensus Classification: Proceedings of the Los Angeles COG International Liver Tumors Symposium. Mod Pathol. doi: 10.1038\/modpathol.2013.80","DOI":"10.1038\/modpathol.2013.80"},{"key":"607_CR15","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1053\/jpsu.2002.32886","volume":"37","author":"F Sasaki","year":"2002","unstructured":"Sasaki F, Matsunaga T, Iwafuchi M et al (2002) Outcome of hepatoblastoma treated with the JPLT-1 (Japanese Study Group for Pediatric Liver Tumor) Protocol-1: a report from the Japanese Study Group for Pediatric Liver Tumor. J Pediatr Surg 37:851\u2013856","journal-title":"J Pediatr Surg"},{"key":"607_CR16","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ejca.2003.06.003","volume":"40","author":"G Perilongo","year":"2004","unstructured":"Perilongo G, Shafford E, Maibach R et al (2004) Risk-adapted treatment for childhood hepatoblastoma. final report of the second study of the International Society of Paediatric Oncology\u2013SIOPEL 2. Eur J Cancer 40:411\u2013421","journal-title":"Eur J Cancer"},{"key":"607_CR17","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/cncr.10632","volume":"95","author":"J Fuchs","year":"2002","unstructured":"Fuchs J, Rydzynski J, Von Schweinitz D et al (2002) Pretreatment prognostic factors and treatment results in children with hepatoblastoma: a report from the German Cooperative Pediatric Liver Tumor Study HB 94. Cancer 95:172\u2013182","journal-title":"Cancer"},{"key":"607_CR18","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1055\/s-2003-39375","volume":"215","author":"B Haberle","year":"2003","unstructured":"Haberle B, Bode U, von Schweinitz D (2003) Differentiated treatment protocols for high- and standard-risk hepatoblastoma\u2013an interim report of the German Liver Tumor Study HB99. Klin Padiatr 215:159\u2013165","journal-title":"Klin Padiatr"},{"key":"607_CR19","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1097\/00043426-200212000-00014","volume":"24","author":"HM Katzenstein","year":"2002","unstructured":"Katzenstein HM, Rigsby C, Shaw PH et al (2002) Novel therapeutic approaches in the treatment of children with hepatoblastoma. J Pediatr Hematol Oncol 24:751\u2013755","journal-title":"J Pediatr Hematol Oncol"},{"key":"607_CR20","doi-asserted-by":"crossref","first-page":"5828","DOI":"10.1002\/cncr.24667","volume":"115","author":"HM Katzenstein","year":"2009","unstructured":"Katzenstein HM, Chang KW, Krailo M et al (2009) Amifostine does not prevent platinum-induced hearing loss associated with the treatment of children with hepatoblastoma: a report of the Intergroup Hepatoblastoma Study P9645 as a part of the Children\u2019s Oncology Group. Cancer 115:5828\u20135835","journal-title":"Cancer"},{"key":"607_CR21","doi-asserted-by":"crossref","first-page":"5650","DOI":"10.1200\/JCO.2009.22.9054","volume":"27","author":"U McDermott","year":"2009","unstructured":"McDermott U, Settleman J (2009) Personalized cancer therapy with selective kinase inhibitors: an emerging paradigm in medical oncology. J Clin Oncol 27:5650\u20135659","journal-title":"J Clin Oncol"},{"key":"607_CR22","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2165\/00148581-200709060-00006","volume":"9","author":"D Walterhouse","year":"2007","unstructured":"Walterhouse D, Watson A (2007) Optimal management strategies for rhabdomyosarcoma in children. Paediatr Drugs 9:391\u2013400","journal-title":"Paediatr Drugs"},{"key":"607_CR23","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1586\/ern.11.103","volume":"11","author":"WC Gustafson","year":"2011","unstructured":"Gustafson WC, Matthay KK (2011) Progress towards personalized therapeutics: biologic- and risk-directed therapy for neuroblastoma. Expert Rev Neurother 11:1411\u20131423","journal-title":"Expert Rev Neurother"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-013-0607-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10147-013-0607-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-013-0607-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,24]],"date-time":"2019-07-24T08:12:29Z","timestamp":1563955949000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10147-013-0607-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,21]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["607"],"URL":"https:\/\/doi.org\/10.1007\/s10147-013-0607-9","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,21]]}}}